{"created":"2023-05-15T14:48:00.702617+00:00","id":65802,"links":{},"metadata":{"_buckets":{"deposit":"ef03a01a-1457-40ed-b287-d77a8624a1c4"},"_deposit":{"created_by":1,"id":"65802","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"65802"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00065802","sets":["10:29"]},"author_link":["648188","648184","648192","648187","648185","648186","648190","648182","648181","648189","648191","648183"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2015-11-07","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"【目的】我々は甲状腺分化癌の転移巣へのFDG集積の有無が予後に影響することを報告した。今回甲状腺分化癌転移巣にFDGが集積した症例での、集積程度と予後との関連性について検討した。【方法】初回I-131治療前のFDG-PETで転移巣にFDGが集積した309例を対象として予後調査を行った。最大追跡期間は、12年であった。PET検査では転移巣の最大SUVmaxを測定し、年齢や転移部位などの他の予後予測因子とを併せて、Kaplan-Meier法でLogrank検定での生存曲線解析とCox回帰モデルを用いて単変量/多変量解析を行った。【結果】10年生存率53.4％であった。Kaplan-Meier法での生存曲線では、SUVmax(P＜0.0001)、性別(P=0.0364)、年齢(P=0.0023)、転移部位(P＜0.0001)において生命予後に有意差があった。多変量解析では、SUVmax(P=0.0011)、年齢(P＜0.0001)、転移部位(P=0.0002)がそれぞれ独立した予後予測因子であると示唆された。【結論】甲状腺分化癌転移巣にFDGが集積した症例において、SUVmaxは独立した強力な予後予測因子であった。 ","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第55回日本核医学会学術総会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"内山, 裕子"}],"nameIdentifiers":[{"nameIdentifier":"648181","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"岡本, 祥三"}],"nameIdentifiers":[{"nameIdentifier":"648182","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"ガートナーフローリアン"}],"nameIdentifiers":[{"nameIdentifier":"648183","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"志賀, 哲"}],"nameIdentifiers":[{"nameIdentifier":"648184","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"平田, 健司"}],"nameIdentifiers":[{"nameIdentifier":"648185","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"真鍋, 治"}],"nameIdentifiers":[{"nameIdentifier":"648186","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小林, 健太郎"}],"nameIdentifiers":[{"nameIdentifier":"648187","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"渡邊, 史郎"}],"nameIdentifiers":[{"nameIdentifier":"648188","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"豊永, 拓哉"}],"nameIdentifiers":[{"nameIdentifier":"648189","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉永, 恵一郎"}],"nameIdentifiers":[{"nameIdentifier":"648190","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"玉木, 長良"}],"nameIdentifiers":[{"nameIdentifier":"648191","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉永 恵一郎","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"648192","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"甲状腺分化癌の転移巣のFDG-PETのSUVmaxは、I-131治療後の予後を予測できる ","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"甲状腺分化癌の転移巣のFDG-PETのSUVmaxは、I-131治療後の予後を予測できる "}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-11-11"},"publish_date":"2015-11-11","publish_status":"0","recid":"65802","relation_version_is_last":true,"title":["甲状腺分化癌の転移巣のFDG-PETのSUVmaxは、I-131治療後の予後を予測できる "],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:56:05.847262+00:00"}